How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

por Short, Nicholas J., Ravandi, Farhad
Publicado 2019

Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted Immunotherapy

por Franquiz, Miguel J, Short, Nicholas J
Publicado 2020

Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors

por Short, Nicholas J., Nguyen, Daniel, Ravandi, Farhad
Publicado 2023

Evaluation and management of measurable residual disease in acute lymphoblastic leukemia

por Abou Dalle, Iman, Jabbour, Elias, Short, Nicholas J.
Publicado 2020

Treatment de-escalation in Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens

por Haddad, Fadi G., Sawyers, Jacki, Short, Nicholas J.
Publicado 2023

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

por Short, Nicholas J., Kantarjian, Hagop, Ravandi, Farhad, Daver, Naval
Publicado 2019

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

por Samra, Bachar, Jabbour, Elias, Ravandi, Farhad, Kantarjian, Hagop, Short, Nicholas J.
Publicado 2020

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

por Zarka, Jabra, Short, Nicholas J., Kanagal-Shamanna, Rashmi, Issa, Ghayas C.
Publicado 2020

Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia

por Aitken, Marisa J. L., Ravandi, Farhad, Patel, Keyur P., Short, Nicholas J.
Publicado 2021

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia

por Guerra, Veronica A., Jabbour, Elias J., Ravandi, Farhad, Kantarjian, Hagop, Short, Nicholas J.
Publicado 2019

Central Nervous System Prophylaxis and Treatment in Acute Leukemias

por Wu, Susan Y., Short, Nicholas J., Nasr, Lewis, Dabaja, Bouthaina S., Fang, Penny Q.
Publicado 2022

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

por Jabbour, Elias, Short, Nicholas J., Jain, Nitin, Haddad, Fadi G., Welch, Mary Alma, Ravandi, Farhad, Kantarjian, Hagop
Publicado 2023

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia

por Bidikian, Aram, Kantarjian, Hagop, Jabbour, Elias, Short, Nicholas J., Patel, Keyur, Ravandi, Farhad, Sasaki, Koji, Issa, Ghayas C.
Publicado 2022

Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse

por Samra, Bachar, Khoury, Joseph D., Morita, Kiyomi, Ravandi, Farhad, Richard-Carpentier, Guillaume, Short, Nicholas J., El Hussein, Siba, Thompson, Philip, Jain, Nitin, Kantarjian, Hagop, Jabbour, Elias
Publicado 2021

Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia

por McCall, David, Roth, Michael, Mahadeo, Kris M., Toepfer, Laurie, Nunez, Cesar, Short, Nicholas J., Daver, Naval, Kadia, Tapan M., DiNardo, Courtney, Yi, Joanna S., Cuglievan, Branko
Publicado 2021

Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside–based low-intensity therapy

por Venugopal, Sangeetha, Borthakur, Gautam, Daver, Naval, DiNardo, Courtney D., Pemmaraju, Naveen, Short, Nicholas J., Abbas, Hussein A., Garcia-Manero, Guillermo, Konopleva, Marina, Ravandi, Farhad, Kadia, Tapan M.
Publicado 2022

Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia

por Dalle, Iman Abou, Paranal, Ronald, Zarka, Jabra, Paul, Shilpa, Sasaki, Koji, Li, Wen, Ning, Jing, Short, Nicholas J., Ohanian, Maro, Cortes, Jorge E., Jabbour, Elias J., Issa, Ghayas C.
Publicado 2020

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

por Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
Publicado 2020

Impact of frontline treatment approach on outcomes of myeloid blast phase CML

por Saxena, Kapil, Jabbour, Elias, Issa, Ghayas, Sasaki, Koji, Ravandi, Farhad, Maiti, Abhishek, Daver, Naval, Kadia, Tapan, DiNardo, Courtney D., Konopleva, Marina, Cortes, Jorge E., Yilmaz, Musa, Chien, Kelly, Pierce, Sherry, Kantarjian, Hagop, Short, Nicholas J.
Publicado 2021

Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy

por Abbas, Hussein A., Sun, Hanxiao, Pierce, Sherry, Kanagal-Shamanna, Rashmi, Li, Ziyi, Yilmaz, Musa, Borthakur, Gautam, DiPippo, Adam J., Jabbour, Elias, Konopleva, Marina, Short, Nicholas J., DiNardo, Courtney, Daver, Naval, Ravandi, Farhad, Kadia, Tapan M.
Publicado 2022